» Articles » PMID: 28265897

Wilson's Disease in China

Overview
Journal Neurosci Bull
Specialty Neurology
Date 2017 Mar 8
PMID 28265897
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Wilson's disease (WD) is an autosomal recessive disorder of copper metabolism. Its incidence is higher in China than in western countries. ATP7B is the causative gene and encodes a P-type ATPase, which participates in the synthesis of holoceruloplasmin and copper excretion. Disease-causing variants of ATP7B disrupt the normal structure or function of the enzyme and cause copper deposition in multiple organs, leading to diverse clinical manifestations. Given the variety of presentations, misdiagnosis is not rare. Genetic diagnosis plays an important role and has gradually become a routine test in China. The first Chinese spectrum of disease-causing mutations of ATP7B has been established. As a remediable hereditary disorder, most WD patients have a good prognosis with an early diagnosis and chelation treatment. However, clinical trials are relatively few in China, and most treatments are based on the experience of experts and evidences from other countries. It is necessary to study and develop appropriate regimens specific for Chinese WD patients.

Citing Articles

Liver diseases: epidemiology, causes, trends and predictions.

Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z Signal Transduct Target Ther. 2025; 10(1):33.

PMID: 39904973 PMC: 11794951. DOI: 10.1038/s41392-024-02072-z.


Dyslipidemia patterns and associated factors in Wilson's disease patients: a clinical analysis.

Wu R, Luo X, Wang X Front Neurol. 2024; 15:1411236.

PMID: 39634771 PMC: 11614754. DOI: 10.3389/fneur.2024.1411236.


Glutathione Attenuates Copper Levels and Alleviates Hepatic Injury in TX Mice.

Wang M, Hu Q, Wang N, Jiang Y, Dong T, Cao S Biol Trace Elem Res. 2024; .

PMID: 39304592 DOI: 10.1007/s12011-024-04384-1.


Gandouling ameliorates liver injury in Wilson's disease through the inhibition of ferroptosis by regulating the HSF1/HSPB1 pathway.

Zhao C, Chen J, Tian L, Wen Y, Wu M, Tang L J Cell Mol Med. 2024; 28(17):e70018.

PMID: 39223962 PMC: 11369335. DOI: 10.1111/jcmm.70018.


Research progress in stem cell therapy for Wilson disease.

Xiong X, Gao C, Meng X, Liu A, Gong X, Sun Y Regen Ther. 2024; 27:73-82.

PMID: 38525238 PMC: 10959646. DOI: 10.1016/j.reth.2024.03.005.


References
1.
Cheng N, Wang X, Yu X, Zhou Z, Gao M, Rao R . [Clinical and genetic study of Wilson's disease in affected twins and siblings]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013; 30(3):261-5. DOI: 10.3760/cma.j.issn.1003-9406.2013.03.002. View

2.
Diao S, Hong M, Huang Y, Wei Z, Su Q, Peng Z . Identification and characterization of a novel splice-site mutation in the Wilson disease gene. J Neurol Sci. 2014; 345(1-2):154-8. DOI: 10.1016/j.jns.2014.07.031. View

3.
Wu Z, Zhao G, Chen W, Wang N, Wan B, Lin M . Mutation analysis of 218 Chinese patients with Wilson disease revealed no correlation between the canine copper toxicosis gene MURR1 and Wilson disease. J Mol Med (Berl). 2006; 84(5):438-42. DOI: 10.1007/s00109-005-0036-y. View

4.
Hu W, Han Y, Xue B, Cheng N, Sun D, Ye D . [Epidemiological study of hepatolenticular degeneration at Hanshan County, Anhui Province]. Zhonghua Yi Xue Za Zhi. 2011; 91(13):894-7. View

5.
Huster D . Wilson disease. Best Pract Res Clin Gastroenterol. 2010; 24(5):531-9. DOI: 10.1016/j.bpg.2010.07.014. View